Endo shareholders will get $80 million in cash and own 49.9% of the combined company, while Mallinckrodt shareholders will ...
Sparsha Pharma transforming drug delivery with cutting-edge transdermal innovations: Dr Veerapaneni: Shardul Nautiyal, Mumbai Saturday, March 15, 2025, 08:00 Hrs [IST] Sparsha Pha ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback